NIAID decides not to go ahead with PAVE 100 HIV vaccine trial

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1648, 2008-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Justification for Thai phase III HIV vaccine trial

Inpharma, Vol. 1, Iss. 1426, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

HIV vaccine fails to Step up in test-of-concept trial

Inpharma, Vol. 1, Iss. 1665, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Joint Inferences on Vaccine Efficacy Against Infection and Disease with Application to the First HIV Vaccine Efficacy Trial

By Cai T.

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 4, 2006-07 ,pp. : 517-538

Taylor & Francis Ltd

Access to resources Recommend Favorite

Monoclonal antibodies get the go-ahead in Japan

Inpharma, Vol. 1, Iss. 1635, 2008-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Trastuzumab gets the go ahead on both sides of the world

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 511, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite